Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters.
Mehibel, Manal
Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters. [electronic resource] - Scientific reports 11 2018 - 16804 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-018-35103-1 doi
Animals
Biomarkers--metabolism
Head and Neck Neoplasms--diagnosis
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Lactic Acid--metabolism
Mice
Monocarboxylic Acid Transporters--antagonists & inhibitors
Oxidative Phosphorylation
Precision Medicine
Prognosis
Pyrimidinones--pharmacology
Thiophenes--pharmacology
Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters. [electronic resource] - Scientific reports 11 2018 - 16804 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-018-35103-1 doi
Animals
Biomarkers--metabolism
Head and Neck Neoplasms--diagnosis
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology
Lactic Acid--metabolism
Mice
Monocarboxylic Acid Transporters--antagonists & inhibitors
Oxidative Phosphorylation
Precision Medicine
Prognosis
Pyrimidinones--pharmacology
Thiophenes--pharmacology